Delivery Order SPE2DB24D2205-SPE2DB25FEDSV
- Not listed
- The Defense Logistics Agency awarded a $20,125.87 delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Wezlana 90 mg/ml syringes. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by June 4, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $33,849.19 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.91 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the place of performance in Conshohocken, PA. This delivery order represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $33,133.71 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,272.69 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of May 5, 2025. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,801.47 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $16,577.11 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Wezlana 90 mg/mL syringes. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 14, 2025, and represents a child delivery order under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,735.28 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 5, 2025, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes with a ceiling value of $13,396.25 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and the work will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $30,488.88 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, utilizes firm fixed price pricing with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDSVDelivery Order
The Defense Logistics Agency awarded a $16,705.71 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/mL syringes, with an ultimate completion date of June 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on June 16, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania, serving as the prime contractor for this pharmaceutical supply delivery. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in delivering critical medical commodities including specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 6/16/25 |